Wuling (Fuzhou) Biotechnology Co., Ltd.
|Business Type:||Manufacturer, Trading Company|
|Location:||Fujian, China (Mainland)|
|Total Employees:||11 - 50 People|
|Total Annual Revenue:||Below US$1 Million|
|Average Lead Time:||15 Day(s)|
Established in December 2003, Wuling (Fuzhou) Biotechnology Co., Ltd. (hereinafter referred as Wuling Biotechnology) engaged in the...
Established in December 2003, Wuling (Fuzhou) Biotechnology Co., Ltd. (hereinafter referred as Wuling Biotechnology) engaged in the scientific research, processing, production and sale of Juncao (Chinese herbs) Ganoderma Lucidum health care products.We have 3 brother companies, including Jiangle Juncao Reishi Biotechnology, Zhongmin Wuling (Beijing) International Health Technology and Huajian Bioengineering Co., Ltd..
Our planting base is located in the southern foot of Wuyi Mountain.It covers an area of nearly 800 acres with a registered capital of RMB 5,000,000 and investment of more than RMB20,000,000. We exclusively introduced the patented technology "Juncao Ganoderma Lucidum Cultivation", choosing nutrient-rich, pollution-free wild Chinese herbs as raw materials, and selecting Ganoderma lucidum strains with strong biological activity and high content of effective ingredients which have passed strict selection and cultivation. Our company scientifically cultivates Juncao Ganoderma lucidum in accordance with organic product standards and artificially collects the purely natural Juncao fungus spore powder. The whole process of production, extraction, processing and packaging are strictly in accordance with national GAP and international GMP standards; the water used in the process of Ganoderma cultivation is from the underground of 80-meter deep, so that factory cultivation of Juncao Ganoderma Lucidum under high-tech and high level of environmental protection conditions has been achieved. Our company has become the first and the only enterprise which cultivates Ganoderma Lucidum by using the Juncao; experts of global Ganoderma lucidum research highly praised it and honored it as the "Leading in the World, First in China" company.
Our R&D Center of Wuling Biotechnology has taken full use of relationships with nationwide major colleges and universities, and cooperated with Shanghai Fudan University, Institute of Chinese Medicine of Beijing 302 Hospital, Peking University Health Science Center and Juncao Biology Institute of Fujian Agriculture and Forestry University to develop new products, conduct analysis and efficiently integrate development of active ingredients in Ganoderma lucidum products.
Over the years, our company has been committed to creating the brand of "Wuling Yang Sheng Tang". In 2006, Juncao Ganoderma lucidum spore powder capsules in "Wuling Yang Sheng Tang" brand acquired National Food and Health Certification; in May 2007, the Health Products Applications Promotion Committee of China Health Care Association approved "Wuling Yang Sheng Tang" Juncao Ganoderma lucidum spore powder capsules as the "key products for promotion" for the Committee and awarded the title of "National Ganoderma Scientific Research Base"; in November 2007, China International Patent and Brand Expo awarded the "Gold Award" to the series products of "Wuling Yang Sheng Tang" Juncao Ganoderma lucidum spore powder capsules; and our products have been distributed in People's Liberation Army General Hospital Beijing 301 Hospital, 302 Hospital, 306 Hospital, 307 Hospital and other major well-known hospitals and nationwide chain pharmacies, and sold at home and abroad, harvesting a good reputation.
Eastern Europe : 21.30%
South America : 18.18%
Factory Size : Below 1,000 square meters
No. of Production Lines : Above 10
No. of R&D Staff : 21 - 30 People
Email to this supplier